Nebenwirkungen · Halaven
HALAVEN 0.44 mg/ml solution for injection · Abschnitt 4.8 · PDF-Seite 6
HOS-124169 · Präparat HOS-095809
System Organ Adverse Reactions – all Grades Class Very Common Common Uncommon Rare or not (Frequency %) (Frequency %) (Frequency %) known Infections and Urinary tract Sepsis (0.5%) (G3/4: infestations infection (8.5%) 0.5%)a (G3/4: 0.7%) Neutropenic sepsis Pneumonia (1.6%) (0.2%) (G3/4: 0.2%)a (G3/4: 1.0%) Septic Shock (0.2%) Oral candidiasis (G3/4:0.2%)a Oral herpes Upper respiratory tract infection Nasopharyngitis Rhinitis Herpes zoster * Blood and Neutropenia (53.6%) Lymphopenia (5.7%) Disseminated lymphatic system (G3/4: 46.0%) (G3/4: 2.1%) intravascular disorders Leukopenia (27.9%) Febrile neutropenia coagulationb (G3/4: 17.0%) (4.5%) (G3/4: 4.4%)a Anaemia (21.8%) Thrombocytopenia (G3/4: 3.0%) (4.2%) (G3/4: 0.7%)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-10-11T15:05:00Z · SHA-256 31249ef6210ad802092fdf0a12213640c232c7a0e17f9862972975afd370495d · Passage 0339b9c3ca7346bb7ce788fe2f569d3b467d7f3dd915568f473ffbb6577063ef · Zeichen 1215–2947 im Abschnitt